QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-9

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 heartsciences-q1-eps-158-beats-209-estimate-sales-1900m

HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(...

 heartsciences-announces-25m-offering

-SEC Filing

 heart-test-laboratories-q4-eps-186-beats-225-estimate-sales-4350m

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(1.86) per share which beat the analyst consensus estimate ...

 heartsciences-signs-first-commercial-customer-westcliffe-health-innovations-uk-for-its-ai-powered-myovista-insights-platform

HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence ("...

 ascendiant-capital-maintains-buy-on-heartsciences-lowers-price-target-to-14

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 ...

 maxim-group-reiterates-buy-on-heartsciences-maintains-12-price-target

Maxim Group analyst Allen Klee reiterates HeartSciences (NASDAQ:HSCS) with a Buy and maintains $12 price target.

 heart-test-laboratories-q2-eps-227-beats-243-estimate

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION